Navigation Links
Varian Medical Systems Receives 510(k) Clearance for Fast and Accurate Acuros(TM) Radiotherapy Treatment Planning Capability
Date:7/21/2009

CHARLOTTESVILLE, Va., July 21 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) today announced that it has received FDA 510(k) clearance for the Acuros(TM) capability offered initially in its brachytherapy treatment planning system. The Acuros clearance was awarded as part of the market-leading Eclipse(TM) treatment planning system.

BrachyVision(TM) Acuros, recently introduced at the American Brachytherapy Society meeting in Toronto, Canada, enables superior dose calculation at unmatched speed. The system enables clinicians to rapidly calculate patient dose with an extremely high level of accuracy*.

"BrachyVision Acuros calculation times tend to average between three and eight minutes depending on the applicator used," says Hosea Mitchell, head of Varian's brachytherapy business unit. "By comparison, the same calculations could take hours or days using the standard Monte Carlo method."

"Securing 510(k) clearance is an important milestone in making this exciting new planning system available to brachytherapy practitioners," adds Mitchell. "Acuros represents a major step forward in terms of accuracy with timeframes that were previously thought unimaginable. It will help clinicians make better decisions about dose to their patients and further their knowledge to make treatments more accurate."

Varian is working exclusively with Transpire Inc., developers of Acuros, to bring the benefits of this fast and precise calculation method to the radiation oncology field. In so doing, Varian becomes the only brachytherapy supplier with this capability in a commercially available product.

Varian Medical Systems, the world leader in radiotherapy, is currently working to integrate the Acuros module into its Eclipse product for external beam radiotherapy treatment planning. BrachyVision Acuros will be among the products on display at the annual meeting of the American Association of Physicists in Medicine (AAPM) at Anaheim, California, from July 26-30.

*Compared to standard techniques using the American Association of Physicists in Medicine TG43 formulism.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, China and Europe and in its 79 sales and support offices around the world. For more information, visit http://www.varian.com/


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding Trabectedin for Relapsed Ovarian Cancer
2. Hormone Therapy Increases Odds of Ovarian Cancer
3. The Perfect Pair: Kelly Ripa and Mark Consuelos Team Up to Fight Ovarian Cancer
4. Varian Medical Systems Management to Present at the Piper Jaffray Cancer Summit
5. Acupuncture, Exercise May Ease Polycystic Ovarian Syndrome
6. Early Menstruation Lowers Odds of Surviving Ovarian Cancer
7. Variants of umami taste receptor contribute to our individualized flavor worlds
8. International Collaboration led by Dr. Pablo V. Gejman,Researcher At NorthShore University HealthSystem's Research Institute, Finds Genetic Association of Schizophrenia to Chromosome 6p Variant
9. Polycystic ovarian syndrome: New light on its causes and its effect on brothers
10. Reduced ovarian reserve associated with increased risk of trisomic pregnancy
11. Varian Medical Systems Schedules Third Quarter FY2009 News Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2017)... ... March 25, 2017 , ... Norland at Swissray is pleased to announce the ... subjects. The ELITE DXA has an active scan window, which is more than double ... fit in the scan area could not undergo an accurate total body bone density or ...
(Date:3/24/2017)... ... March 24, 2017 , ... Digital Scientists, a software innovation lab specializing in ... a Greenville, South Carolina location. The lab has set up shop at ... been working with South Carolina clients for years from our office here in Atlanta,” ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mlynarek ... services to families and business owners across eastern Michigan, is connecting with the ... struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry works to ensure ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... panels at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. ... Administrative Record, The majority of cases litigated under ERISA involve claims for long-term ...
(Date:3/24/2017)... ... March 24, 2017 , ... Judy Buchanan, co-owner of ... Frederick, MD. Judy says, “I am passionate about sharing Reiki as a holistic, ... difficult and challenging time.” , A Certified Medical Reiki™ Master trained by Raven ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Oregon and PUNE, India , March 24, 2017 ... Research, titled, "Spine Bone Stimulators Market: Global Opportunity Analysis and Industry Forecast, 2014-2022," ... is projected to reach $724 million by 2022, growing at a CAGR of ... ... Allied Market Research Logo ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Business Report" report to their offering. ... This report analyzes the worldwide markets for Dental Implants ... Canada , Japan , ... , and Rest of World. Annual estimates and ...
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research and ... (IPF) Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with ... Corporation, Merck & Co., Inc., Biogen and Sanofi are involved in the ... candidates, of which one is in Phase III stage, 15 are in ...
Breaking Medicine Technology: